Ambu downgrades due to covid-19 and logistical challenges
The medtech firm is downgrading its annual guidance as operations and the firm's logistics chain are still being affected by the pandemic.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
On Thursday evening, the medtech company lowered its guidance, as the covid-19 pandemic continues to affect the number of operations being performed while also disrupting the firm's supply chain, according to an Ambu press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu gets recommendation from FDA, analyst doubts effect
For subscribers
FDA recommends single-use bronchoscopes
For subscribers
FDA approves new Ambu product
For subscribers
